FAS and metabolic dysfunction-associated steatohepatitis: Subsequently, when we subclassified the patients according to hepatic histopathological classification, we found higher levels of hepatic mRNA relative abundance of FAS in SS subjects than in NL; moreover, these levels were higher in NASH than in NL patients (Figure 4B).